The Medical Imaging Research Group is a research group focused on the use of all medical imaging modalities for clinical and preclinical research in several medical areas. Our main goals have been: 1) set up of new methodologies for clinical diagnosis, 2) find imaging- and blood- based biomarkers for disease detection and management 3) setting up new healthcare apps, and 4) identify the pathological mechanisms and inter-organ crosstalk in insulin resistance in Type 2 Diabetes. In addition, we are working on the generation of software imaging tools to: 1) analyse images automatically and 2) perform clinical diagnosis of cardiovascular and hepatic diseases. We focus mainly on these organs because there are few analytical tools available with many limitations. Finally, we are working on the development of new diagnostic agents (radioactive and non-radioactive) for different molecular imaging modalities as well as radiotherapeutic and theragnostic agents for oncology applications.

Group Leader
José Raul Herance Camacho

Principal Investigator (PI)
Santiago Aguade Bruix Serres Créixams, Xavier Ana Maria Rodriguez Arana

Researchers
Julia Baguña Torres Cristina Gámez Cenzano Maria Nazarena Pizzi Cuellar Calabria, Hug Roque Pérez, Albert Diego A Villasboas Rosciolesi Joan Castell Conesa Marc Simó Perdigó Manuel Escobar Amores Carles Lorenzo Bosquet Gemma Cuberas Borros Juan Pablo Salazar Gutierrez Gemma Burcet Rodríguez Dellepiane Clarke , Fiorella Navales Mateu, Ignacio Mª Jose Moreno Negreie Mº Teresa Veintemillas Araiz Daniel Eiroa Gutierrez Mònica Velasco Nuño Esperanza Medina Gutiérrez Nuria Roson Gradaille Jorge Guillermo Romero Farina Maria Boronat Ferrater Marta Barios Profitos

PhD Students
Amparo García Burillo Mª Àngels Hernández Fructuoso Beatriz Santos Montero Xingpeng Xiao Marina Llenas Martinez Clara Ramirez Serra Carina Espinet Coll Queralt: Martin Saladich Álvaro Valverde Moya

Lab Technicians
Carolina Aparicio Gómez Johanna A Troya Balseca Irati Caballero Bermejo Itziar Busquets Sáez Carmen Gloria Franco Monterroso

Nursing and Technical Staff
Eduard Albuixech Ginesta Inés Carolina Balón Llerena Joan Barbeta Sanchez Miguel Descalzo Pérez Lluís Gabalda Martínez Héctor García Fernández Mireia Iniesta Ambrós Julio Linares Molina Mª Carmen López Arribas Sergio López Gandul Carmen Sanchez Suarez Albert Tomas Corella

35

PUBLICATIONS

195

IMPACT FACTOR

5.57

AVERAGE IMPACT FACTOR

SELECTED ARTICLES

Roque A, Pizzi MN
18F-FDG PET/CT and cardiac CTA in transcatheter aortic valve implanted endocarditis: Still at the beginning of a long road.
J Nucl Cardiol. 2021 Oct;28(5):2083-2085.
DOI: 10.1007/s12350-020-02035-1
IF: 5.952

Roque A, Blanco E, Aguade-Bruix S, Fernandez-Hidalgo N, Cuellar-Calabria H, Pizzi MN
Long-term intense FDG uptake in a non-infected prosthetic aortic heart valve implanted 18 years ago.
J Nucl Cardiol. 2021 Aug 19
DOI: 10.1007/s12350-021-02764-x
IF: 5.952

Romero-Farina G, Aguade-Bruix S
Perspective and future direction of intraventricular mechanical dyssynchrony assessment.
J Nucl Cardiol. 2021 Feb;28(1):65-71
DOI: 10.1007/s12350-019-01604-3
IF: 5.952

Domingo-Ortí I, Lamas-Domingo R, Ciudin A, Hernández C, Herance JR, Palomino-Schätzlein M, Pineda-Lucena A
Metabolic footprint of aging and obesity in red blood cells.
Aging (Albany NY). 2021 Feb 19;13(4):4850-4880
DOI: 10.18632/aging.202693
IF: 5.682

Garcia-Burillo A, Monturiol-Duran JA, Iglesias-Felip C, Villasboas-Roscioles, Castell-Conesa J
Follicular Thyroid Carcinoma Metastases on Round Ligament of Liver.
Clin Nucl Med. 2021 Apr 1;46(4):326-328
DOI: 10.1097/RLU.000000000000352
IF: 7.794

Early molecular nanoDIAGnostics of Brain tumors using Immune-PET (DIAGBI)
Principal Investigator: J Raul Herance
Agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 216,102€
Period: 2021-2024

Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies
Principal Investigator: J Raul Herance
Agency: Innovative Medicines Initiative (IMI)
Funding: 514,560€
Period: 2019-2024

QUSTom – Quantitative Ultrasound Stochastic Tomography – Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.
Principal Investigator: Rodriguez Arana, Ana Maria
Agency: EIC-PATHFINDER OPEN 2021
Funding: 400,871€
Period: 2021-2024

Insulin resistance in type 2 diabetes: unraveling the pathogenic mechanism between organs
Principal Investigator: J Raul Herance / Santiago Aguadé
Agency: Instituto de Salud Carlos III
Funding: 159,720€
Period: 2021-2023

nTRACK: Multimodal nanoparticles for structural and functional tracking of stem cell therapy on muscle regeneration..
Principal Investigator: J Raul Herance
Agency: Horizon2020
Funding: 1.019.687,5€
Period: 2017-2022

SYNTHROCYTE: ERYTHROCYTE-MIMICKING REAGENT AND FAST METHODS FOR PATHOGEN CHARACTERIZATION AND SEROLOGY TESTING
Priority Number: PCT/EP2020/066292
Priority Date: 17/12/2020
Applicants: Baldrich E, Sánchez A, Antón A, Andrés C, Herance JR, Pumarola T